Inkron to Join the LaSAR Alliance

Inkron joins the founders of LaSAR: STMicroelectronics, Osram, Applied Materials, Dispelix, MegaOne

The LaSAR Alliance was established to create an ecosystem of companies to enable the design and manufacture of Augmented Reality (AR) wearable devices.

HELSINKI, FINLAND, May 9, 2021 /EINPresswire.com/ — Inkron, a Nagase Group Company, manufacturer of high and low refractive index (RI) optically clear coating materials, joins the LaSAR Alliance.

The LaSAR Alliance (Laser Scanning for Augmented Reality) was established to create an ecosystem of like-minded companies and organizations to foster and encourage the development and promotion of technologies, components, devices, techniques, and solutions to enable the efficient design and manufacture of Augmented Reality (AR) wearable devices including smart glasses and head-mounted displays. The goal of LaSAR is to create a marketplace for ideas where members can exchange and share information, collaborate and partner to create, build and grow effective and compelling LBS (Laser Beam Scanning) based AR-solutions, share best practices and help to drive the market growth for augmented reality wearables in general.

Inkron looks forward to working with LaSAR’s founding members: STMicroElectronics, Osram Opto Semiconductors, Applied Materials, Mega1 and Dispelix as well as with the new members. Inkron’s portfolio of Nano Imprintable high index coatings combined with the high RI optical black designed to eliminate lens edge reflections offer a cutting -edge library of materials for up-coming projects.

“LaSAR welcomes Inkron Oy to the Alliance and looks forward to their contributions to driving the growth of Augmented Reality wearable devices through advances in the state-of-the-art in laser-beam scanning solutions,” said Bharath Rajagopalan, Chair of the LaSAR Alliance and Director, Strategy Marketing at STMicroelectronics. “Inkron offers vital solutions for the AR glass manufacturing process, and we expect their participation to further fuel the technology and growth of this dynamic market.”

About Inkron

Inkron, a member of the Nagase Group, is a developer and manufacturer of high and low Refractive Index (RI) coating materials. These industry-leading optical coatings cover a record-breaking RI range between 1.1 and 2.0 in the VIS/NIR wavelength range. The high RI materials are optimized for the Nano Imprint Lithography (NIL) process. Targeted applications include DOE (Diffractive Optics Elements) such as Waveguides for XR devices, optical diffusers, LIDAR and other photonic applications. High refractive index materials are complemented by Inkron’s matching low refractive index materials with an RI range of 1.1-1.4. Typical applications of the low RI materials include anti-reflective coatings (visible and NIR range), waveguide claddings and adhesive layers. Additionally, a new high index optical black is released. The combination of a substrate matching refractive index and a high optical density of this optical black effectively removes the edge reflections of AR lenses and other optical devices.

For more information:
Jukka Perento, Inkron Oy (www.Inkron.com)
E-mail: Jukka.Perento@inkron.com Tel: +358 40 5910 419

Jukka Perento
Inkron Oy
+358 40 5910419
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

For a sustainable future and achieve its mission towards a cleaner and vibrant future RoCo Global joins REMADE Institute

sustainability, Recycling, Chemistry of materials

RoCo Global joins REMADE institute

RoCo is now part of REMADE institute.

PITTSBURGH, PA, USA, May 7, 2021 /EINPresswire.com/ — RoCo Global joins REMADE Institute to achieve its mission towards a vibrant and cleaner future.

RoCo Global is proud to announce that it has joined the REMADE Institute. RoCo Global is a small, Pittsburgh-based company with specific goals toward helping the world transition to a Circular Economy, increase the efficiency of resources used in manufacturing, reduce emissions, conserve resources, and create and sustain clean economy jobs through innovation in materials science and chemistry.
REMADE CEO Nabil Nasr said the institute, a public-private partnership established by the U.S. Department of Energy, is pleased to have RoCo Global as its newest member. “RoCo Global’s mission to work towards sustainability is aligned directly with REMADE’s,” Nasr said. “We are dedicated to accelerating the U.S.’s transition to a Circular Economy and creating a sustainable and competitive manufacturing future that makes the most efficient use of resources.”

RoCo Global’s CEO Dr. Nulwala sees them REMADE Institute as an important milestone for the company development. He said “RoCo Global’s mission to work towards sustainability is aligned with REMADE institute. We are dedicated to accelerating the U.S.’s transition to a circular economy and creating a sustainable and competitive manufacturing future that makes the most efficient use of resources,”
Through RoCo Global’s membership with REMADE, RoCo will engage with other partners in the Institute to developg solutions that can decrease greenhouse gas emissions significantly, reduce waste, and create new jobs. As Circular Economy concepts continue to gain momentum, companies will be pushed to think beyond the current “take, make, dispose” model. RoCo Global will play a key role in developing new technologies and has a roadmap towards circular economy with carbon dioxide as the core feedstock material.

About RoCo Global:
RoCo Global was formed in 2014 is an advanced materials company that develops innovative technologies to solve global environmental issues. RoCo Global is a demonstrated leader in carbon dioxide capture, carbon dioxide utilization, polymer recycling and ionic liquid materials. Our Integrated Research approach and commitment to Open Innovation, make RoCo the ideal research and development partner for companies, large and small, as well as universities and research institutions. Learn more at https://roco.global/

About REMADE:
Founded in 2017, REMADE is a Manufacturing USA™ Institute and public-private partnership established by the U.S. Department of Energy. REMADE is the only national institute focused entirely on the development of innovative technologies to accelerate the U.S.’s transition to a Circular Economy. In partnership with industry, academia, and national laboratories, the REMADE Institute enables early-stage applied research and development that will create jobs, dramatically reduce embodied energy and greenhouse gas emissions, and increase the supply and use of recycled materials. The cumulative, five-year embodied energy savings, greenhouse gas reduction and increase in recycled materials use expected to result from REMADE’s investment is approximately 1 Quad of energy (approximately 180 million barrels of oil per year), about 50 million metric tons of CO2equivalent greenhouse gas reduction, and more than a 40 million metric tons per year increase in the supply and use of recycled materials, respectively. For additional information about REMADE, visit www.remadeinstitute.org.

Tweet This:
For a sustainable future and achieve its mission towards a cleaner and vibrant future RoCo Global joins REMADE Institute.

RoCo Global contact:
Batool Nulwala
Business Manager
1816 parkway view drive, Pittsburgh, PA 15205
info@roco.global
412-564-3289

REMADE media contact:
Megan Connor Murphy
Director, Marketing and Communications
REMADE Institute
mconnormurphy@remadeinstitute.org
585-213-1036

Batool Nulwala
RoCo Global
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

TESTER, MORAN & ISAKSON HAVE BEEN CONCEALING THE USE OF AGENT ORANGE AT THE FORMER FORT MCCLELLAN ARMY BASE

The agent orange usage list at Fort McClellan along with other herbicides. Taken from the 1990 Army Corps Of Engineers site review of McClellan.

The pesticides usage list for the same 3 year period as agent orange at Fort McClellan. Taken from the 1990 Army Corps of Engineers site review.

The report cover by the Army Corps Of Engineers where the agent orange use was found at Fort McClellan

Three different Chairmen of the Senate Veterans Committee & all have worked to block a GAO Report authorization to declare McClellan as an agent orange site

ALBANY, NEW YORK, USA, May 7, 2021 /EINPresswire.com/ — During the primary years of the Vietnam War, the herbicide chemical known as agent orange was pre-mixed at Dow Chemical factories and then shipped overseas to the jungles of U.S. combat zones. The compound could also be made on site at any location by simply buying the separate chemical ingredients for it. The main ingredients for agent orange are known as 2,4-D and 2,4,5-T. As the years have passed, veterans everywhere have learned how to screen old military environmental reports for any mention of the dreaded chemicals.

After conducting sweeping internet searches to find the environmental report history for the former federalized Army base known as Fort McClellan, Alabama, the veterans who were stationed there have identified ten significant toxic spill sources that makes up their current health risk profile. One of the ten hazardous sources on their list, is the collection of papers verifying the use of 2,4-D and 2,4,5-T chemicals along with hundreds of pounds of other herbicide and pesticide products that were all used during the same three-year period at the base. They say that the mixtures of these products, when placed alongside all other known multiple spill sources that took place during the same range of years, forms the likelihood of a cumulative cause to their health conditions.

The collection of papers was first brought to the attention of the former congressional staffers for Senator Johnny Isakson of Georgia who was the chairman of the Senate Veterans Committee at the time. When he suddenly left Congress, the papers and issues of the veterans were rolled over to the staffers for Senator Jerry Moran. When the majority flipped in the Senate, the veteran’s issues and papers were rolled over to the staffers for Senator Jon Tester. To this very minute, the issue of agent orange used at Fort McClellan remains unprocessed, neglected, abandoned, unresolved, and largely ignored by Tester’s office and the current Senate Veterans Committee. All the men have no military service.

The Government Accountability Office (GAO) has published an official site list of all United States military locations where agent orange was used or stored during the Vietnam War years and thereafter. Fort McClellan is not on the list. The Dept. of Veterans Affairs has been deferring to the GAO version of the list in their processing of veteran’s disability claims. In order to have the base added to the GAO list, then an authorization letter has to be issued by a Veterans Committee or some other member of Congress to commence a new report showing the site changes. The veterans have done the preliminary work with the committee staffers to set up the boundary of questions that was to be probed or answered by the new report. The agent orange matter is included in their range of proposed topics. But the delivery of an authorization letter to start the report sits dormant at the hands of Senator Jon Tester of Montana.

At the end of February 2021, the activist for the veteran’s group, Sue Frasier, received a phone call meeting with a resigning staffer from Senator Tester’s office alleging that he was issuing a letter to the GAO that very week. The letter was to see if they would voluntarily add the new Fort McClellan site information for agent orange storage and use. Since that time, there has been no reply from any new staffers from Tester’s office either to verify the letter was sent or to speak on the matter of them issuing the other authorization letter for the entire new report. Veteran’s disability cases at the VA are languishing in limbo or are falsely denied by clerical raters based on the missing site information at the GAO and VA. Some of the effected veterans are medically matching to the “presumptive” diseases that are listed for other groups who are claiming agent orange exposures, but they are getting denied by the VA because of the GAO locations technicality.

The veterans have been frustrated and outraged by the lack of urgency and attention from Tester’s office. The patient group says that Senator Tester has been advancing the issues of other toxic exposure groups at the committee who are not holding the level of certainty for toxic site papers and matching published health sciences to the extent that they are. They consider the obstructionism that has come so far from Tester, Moran, and Isakson as the product of civilian incompetence. The veterans have long complained that the Senate Veterans Committee has been used as a deceptive platform for political and news media exploitation rather than a fair and equal oversight and legislative process available to all veteran’s patient groups. According to them, the committee works from a charade agenda where only certain patient groups are helped with the full package of hearing and news media grandstanding, while at the very same time, other groups who are better documented in their causes are blocked or held in perpetual limbo and concealment.

The veterans have recently made a consulting connection with offices at the Environmental Protection Agency regarding their overall cause stemming from Fort McClellan service. But they also insist that a new GAO Office change still must be made to establish the base as a former agent orange usage site. AO disability claims stemming from service at McClellan will not likely be resolved by any expert assistance that may come from the Environmental Protection Agency. The veterans are hoping that the dislodging of one assistance venue will also leverage the dislodging of the GAO report project in their favor.
+
+
UPDATE TO THE APRIL 20, 2021 STORY ABOUT THE NUCLEAR REGULATORY COMMISSION: A meeting has been held between the veteran’s group and the Nuclear Regulatory Commission. It was revealed at that time that NRC inspectors had tried a few times to gain access to the Chemical Corps environmental papers for Fort McClellan but were denied access under the excuse it was classified. The NRC was helpful & assisting to the veterans group.
+
+

Sue Frasier, activist
Toxic Exposure Army Veterans of Fort McClellan
ft_mcclellan_vets1@yahoo.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Advanced Innovative Partners Receives FDA'S Orphan Drug and RPD Designations for Hepatoblastoma Imaging Biomarker

MIAMI, FLORIDA, UNITED STATES OF AMERICA, May 6, 2021 /EINPresswire.com/ — Advanced Innovative Partners (AIP) is pleased to announce that the U.S Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease (RPD) Designation for a radiopharmaceutical for Positron Emission Tomography (PET) imaging, diagnosis and clinical management of pediatric patients with Hepatoblastoma (HB).

Roseanne Satz, AIP’s Chief Executive Officer commented “We are very excited to be contributing to advancing management for children suffering from rare diseases. In addition to the award of these designations, we are now completing our IND application enabled by a successful meeting with FDA.”

HB is a malignant hepatic tumor and is the most common pediatric liver cancer. It is more common in patients with familial adenomatous polyposis and can occur in patients with other pre-existing liver conditions. About 5% of HB cases are associated with genetic factors, especially overgrowth syndromes. HB is the most common pediatric liver tumor in children under 5 years old and accounts for approximately 1-4% of all malignant tumors in children. 0.5-1.5 children per million are diagnosed with HB each year in the US, with incidence increasing in recent years.

The FDA defines an RPD as a serious or life-threatening disease primarily affecting individuals aged 18 years or younger that impacts fewer than 200,000 children in the United States. The program is intended to facilitate development of new drugs and biologics for the prevention and treatment of RPDs. Hepatoblastoma is recognized as a rare pediatric disease by the National Institute of Health’s Office of Genetic and Rare Diseases (GARD), the National Cancer Institute’s Surveillance, Epidemiology and End Results Program (SEER) and the European Community’s Committee for Orphan Medicinal Products.

Upon FDA marketing approval of the Hepatoblastoma imaging biomarker with RPD designation, AIP would be eligible to receive a tradable Priority Review Voucher (PRV). A PRV allows a company to use the voucher to accelerate the FDA review period of a New Drug Application (NDA). The voucher, if awarded, may be sold or transferred; PRVs have been sold for between US$ 68 million and $ 350 million.

About AIP

Advanced Innovative Partners is a late-stage clinical biotechnology company focused on development diagnostics and companion therapeutics in oncology, are pediatric diseases, and neurology. True to our name, our mission is to deliver transformative science to people with underserved medical needs, is focused on specialty pharmaceuticals enabling personalized medicine.

Note Regarding Forward-Looking Statements

This press release contains "forward-looking" statements that involve substantial risks and uncertainties. All statements other than statements of historical facts, including statements regarding our future financial condition, timing for and outcomes of clinical results, business strategy and plans and objectives for future operations, are forward-looking statements. These forward-looking statements include terminology such as "believe," "will," "may," "estimate," "continue," "anticipate," "contemplate," "intend," "target," "project," "should," "plan," "expect," "predict," "could," "potentially" or the negative of these terms. Forward-looking statements are our current statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, our anticipating significant milestones in 2020 and 2021, the timing of our ongoing and planned clinical development, including our ability to support the launch of a new product and ship to specialty pharmacies.

Juanita Gallego Roa
Advanced Innovative Partners
+1 561-757-8666
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Virtual Engineering Meetings for Graphalloy® Bushing Solutions

Eric Ford, VP of Sales & Marketing for Graphalloy®

Eric Ford, VP of Sales & Marketing for Graphalloy®

Due to travel restrictions, these meetings have been a productive way to “visit” customers and help engineer upgrades to the Graphalloy bushing material

YONKERS, NY, UNITED STATES, May 6, 2021 /EINPresswire.com/ — Graphite Metallizing Corporation, the manufacturer of self-lubricating GRAPHALLOY® bushing materials, announces virtual engineering meetings for customers who need bearing/bushing solutions in tough pumps, conveyors, ovens, and other extreme applications.

During the past year, Eric Ford, VP of Sales & Marketing for Graphalloy, has been promoting virtual meetings with global sales reps unable to visit customers in-person due to Covid-19 restrictions. The sales reps and customers have responded very positively.

“We are conducting multiple meetings per week now, all over the world,” says Eric. “This solution allows us to present a graphic overview of the Graphalloy product line, including successful applications, while our engineers answer any of the customer’s technical questions regarding design considerations.”

“These virtual meetings benefit our customers by allowing various members of our support team to participate, while the customer can invite multiple members of their team, from various locations, to attend at the same time. It’s much more dynamic and detailed than simply sending emails back and forth. Overall, it creates a great environment to discuss the customer’s various bearing needs and offer Graphalloy solutions that can meet those needs.”

Graphalloy Bushings offer solutions in places where traditional bearing lubricants will not work, including high temperature applications, clean environments, submerged operation applications, and more. The Graphalloy material is self-lubricating, non-galling, and can withstand temperatures from -400°F (-240°C) to +1000°F (+535°C). These qualities also make it a solution for pump bushings and wear rings, especially in low lubricity service and in pumps where dry start, dry running, or flashing are issues.

Graphalloy, a graphite-metal alloy, is available in over 100 grades with specific properties that meet a wide range of engineering solutions and specifications. Graphalloy bearings have operated for 20 years and longer in some applications. Common applications for Graphalloy bushings include pumps, wastewater, ovens, dryers, dampers/louvers, kilns, conveyors, submerged, and more.

FDA acceptable grades of Graphalloy are available for use in food service equipment. NSF® and WRAS grades of GRAPHALLOY material are also available for use in municipal well pumps and water treatment plant applications.

To discuss your application further with Graphalloy sales engineers, contact sales(at)graphalloy(dot)com. For more information about Graphite Metallizing and its products, please visit us online at https://www.graphalloy.com or call +1-914-968-8400.

Eric Ford
Graphite Metallizing Corporation
+1 914-968-8400
email us here


Source: EIN Presswire

Romeo Power Investors With Losses Greater Than $75,000 – Kehoe Law Firm, P.C. Securities Class Action Investigation

Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C.

Class Action Investigation On Behalf Of Romeo Power Investors Who Have Suffered Significant Losses

PHILADELPHIA, PA, USA, May 6, 2021 /EINPresswire.com/ — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ROMEO POWER, INC. (f/k/a RMG ACQUISITION CORP) (“Romeo Power” or the “Company”) (NYSE: RMO) to determine whether the Company engaged in securities fraud or other unlawful business practices.

On April 16, 2021, a class action lawsuit was filed in United States District Court, Southern District of New York (1:21-cv-03362), on behalf of Romeo Power investors who purchased, or otherwise acquired, the Company’s securities between October 5, 2020 through March 30, 2021, both dates inclusive (the “Class Period”).

According to the class action complaint, unknown to investors, Romeo Power was suffering from an acute shortage of high-quality battery cells, which are key raw materials for Romeo Power’s battery packs and modules, due to supply constraints. The complaint alleges that contrary to the Romeo Power Defendants’ representations, (i) Romeo Power had only two battery cell suppliers, not four; (ii) the future potential risks that Defendants warned of concerning supply disruption or shortage had already occurred and were already negatively affecting Romeo Power’s business, operations and prospects; (iii) Romeo Power did not have the battery cell inventory to accommodate end-user demand and ramp up production in 2021; (iv) Romeo Power’s supply constraint was a material hindrance to Romeo Power’s revenue growth; and (v) Romeo Power’s supply chain for battery cells was not hedged, but, in fact, was totally at risk and beholden to just two battery cell suppliers and the spot market for their 2021 inventory. Given the supply constraint that Romeo Power was experiencing during the Class Period, the Romeo Power Defendants had no reasonable basis, according to the complaint, to represent that the Company had the ability to meet customer demand and that it would support growth in revenue in 2021.

INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $75,000 ARE ENCOURAGED TO CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, KCAULEY@KEHOELAWFIRM.COM, SECURITIES@KEHOELAWFIRM.COM, INFO@KEHOELAWFIRM.COM, TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.

Kevin Cauley, Director, Client Relations
Kehoe Law Firm, P.C.
+1 215-792-6676
info@kehoelawfirm.com


Source: EIN Presswire

ChemoCentryx Investors With Losses Greater Than $100,000 – Kehoe Law Firm, P.C. Securities Class Action Investigation

Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C.

Class Action Investigation On Behalf Of ChemoCentryx Investors With Significant Losses

PHILADELPHIA, PA, USA, May 6, 2021 /EINPresswire.com/ — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI) to determine whether the Company engaged in securities fraud or other unlawful business practices.

On May 5, 2021, a class action lawsuit was filed in United States District Court, Northern District of California (3:21-cv-03343), on behalf of ChemoCentryx investors who purchased, or otherwise acquired, the Company’s securities between November 26, 2019 and May 3, 2021, both dates inclusive (the “Class Period”).

According to the class action complaint, throughout the Class Period and in violation of the Exchange Act, the ChemoCentryx Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts to investors. Specifically, the ChemoCentryx Defendants, allegedly, misrepresented and/or failed to disclose to investors that (1) the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis; (2) the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan; (3) these issues presented a substantial concern regarding the viability of ChemoCentryx’s NDA for avacopan for the treatment of ANCA-associated vasculitis; and (4) as a result of the foregoing, the ChemoCentryx Defendants’ public statements were materially false and misleading at all relevant times.

INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, CHEMOCENTRYX SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, KCAULEY@KEHOELAWFIRM.COM, SECURITIES@KEHOELAWFIRM.COM, INFO@KEHOELAWFIRM.COM, TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.

Kevin Cauley, Director, Client Relations
Kehoe Law Firm, P.C.
+1 215-792-6676
info@kehoelawfirm.com


Source: EIN Presswire

SL Announces Latest Version of RTView Enterprise with Expanded Support for Monitoring Customization

A custom, dynamic heatmap demonstrates the real-time health state of infrastructure in the context of business services

New features enable users to custom displays and alerts via simple configuration and no programming.

With the addition of the new customization capabilities in version 6.0, our users can more easily demonstrate IT alignment with business priorities.”

— Andy Hall, CEO of SL Corporation

RIVERSIDE, CALIFORNIA, USA, May 6, 2021 /EINPresswire.com/ — SL, the global leader in the monitoring of custom business applications built on messaging and integration middleware, today announced the availability of RTView Enterprise version 6.0 with expanded support for monitoring and alerting customization.

RTView is a non-intrusive, low ownership cost, and predominantly agentless monitoring system that provides unique visibility into messaging and integration middleware and the applications and services built on them.

“Users can now blend information about availability and performance with business KPIs and identify patterns that are more useful to the business, said Andy Hall, CEO of SL Corporation. “With the addition of the new customization capabilities in version 6.0, our users can more easily demonstrate IT alignment with business priorities.”

Custom Monitoring and Alerting
Some of the new capabilities include enhancements to the Custom Display Designer announced in the previous product release. Users are able to quickly create and share custom and views of application and infrastructure performance for different audiences including application and service support teams owners. Displays are configured with an easy to use user interface without programming.

A new Custom Alert Designer enables users to configure custom alerts via an easy-to-use drag and drop UI. Administrators can quickly create and deploy custom alerts that behave like built-in alerts in the Alert Administration page, all with just a few clicks and with no programming.

RTView Enterprise now supports InfluxDB as a standard method for importing data into RTView. This means RTView users can now take advantage of more than 200 Influx connectors to popular systems and configure custom displays and alerts for these systems from Influx data via a simple UI.

Solace PubSub+ Monitoring
Enhanced support for Customization with the addition of Custom Alert Designer. Users can now create custom displays and alerts via a simple UI without having to do any programming.

Addition of sparklines to Solace solution package summary displays to aid in understanding of critical performance and availability metrics

Update of Ingress/Egress terminology to Incoming/Outgoing messages

Enhance StatsPump and statsds to handle removal of broker connections

For more information on what’s new in RTView Enterprise 6.0, view the blog post: RTView Enterprise 6.0 Featured Product Updates

About SL:
SL is a California-based software company that develops real-time monitoring, visualization and diagnostic software for Global 1000 and mid-market companies whose businesses depend on complex, high-performance applications. The company has deep expertise in the monitoring of custom, distributed applications running in heterogeneous middleware environments and provides packaged monitoring and visualization solutions for leading platforms including Solace, Kafka, TIBCO, and SoftwareAG.

Anne Vincent
SL RTView
+1 514-665-6793
avincent@rtview.com
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

MyWay Mobile Storage of Grand Rapids provides support for GVSU Athletics’ 2021 NCAA DII Outdoor Track & Field

The 2021 NCAA DII Men's and Women's Outdoor Track and Field will be one of the most exciting sporting events in West Michigan.

We are pleased to support the GVSU as they host this event.”

— Sean Sickmund

GRAND RAPIDS, MICHIGAN, UNITED STATES, May 5, 2021 /EINPresswire.com/ — MyWay Mobile Storage of Grand Rapids, is pleased to provide portable storage containers for GVSU Athletics for the 2021 NCAA DII Men's and Women's Outdoor Track and Field. The portable storage containers will be utilized to store equipment during the event.

MyWay Mobile Storage of Grand Rapids General Manager Sean Sickmund stated, “We are pleased to support GVSU as they host this event.”

The 2021 NCAA DII Men's and Women's Outdoor Track and Field will be one of the most exciting sporting events in West Michigan. The events will be held at Grand Valley’s Track and Field Stadium at the Allendale campus.

Visit the NCAA website to learn more about the event, event location, and event times. https://www.ncaa.org/championships/division-ii-mens-and-womens-outdoor-track-and-field

Based in Grand Rapids, Michigan, MyWay Mobile Storage is a leading franchise for do-it-yourself moving and portable storage solutions with facilities in Colorado, Maryland, Michigan, Missouri, Pennsylvania, and Utah.

About MyWay Mobile Storage of Grand Rapids: MyWay Mobile Storage is a leading provider of moving and storage solutions and located in a spacious 18,000 square foot facility in Walker, Michigan. MyWay provides quick and easy do it yourself moving containers that can be delivered right to your door and stored in their climate controlled secure storage facilities. To learn more about MyWay Mobile Storage, visit www.mywaystorage.com, or on Facebook at www.facebook.com/mywaystorage or call 888-336-9929 to speak with a friendly and knowledgeable Moving & Storage Consultant.

Sean Sickmund
MyWay Mobile Storage of Grand Rapida
+1 616-232-6957
sickmunds@mywaystorage.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

HAPInss Brands™, Announces New Manufacturing Alliance On Emerging Trends & Innovations For Nutritional Science Systems

AmpLIFEi

AmpLIFEi

HAPInss Brands

Alternative Labs

Innovating Duo Robert Oblon & Kevin Thomas, Join Forces Once Again To Collaborate On Emerging Trends & Innovations For Unparalleled Nutritional Science Systems.

GREENWOOD, INDIANA, USA, May 5, 2021 /EINPresswire.com/ — HAPInss Brands™, one of the world's fastest-growing health and wellness companies today announced that it is has completed a custom manufacturing agreement for product development, innovation, and supply with Alternative Laboratories, LLC., respected as one of the most innovative and successful pioneers of liquids, powders, tablets, capsules, and other unique nutritional supplements and delivery systems, with 1000’s of developed and nationally branded products, including over 50 first to market concepts and technologies.
“Understanding that Kevin invents and manufacturers products for many, many companies, I’m honored that we are able to create one-of-a-kind, life-changing products with his expertise, and our scientific advisory board,” says Robert Oblon, “that is helping us become the fastest-growing company in our industry, yet again.”

Additionally, the customer manufacturing agreement will allow HAPInss Brands™ to distinguish its products from others in the direct marketing space by creating uniquely functional formulations and delivery systems with the help of the HAPInss Brands™ Scientific Advisory Board consisting of doctors, nutritionists, and health professionals to bring next-generation formats to the market, allowing HAPInss Brands™, to further expand its industry-leading portfolio of product and manufacturing capabilities.

“We are delighted to collaborate with such a skilled and reputable formulating visionary like Mr. Thomas,” stated Larry Cantrell, President of HAPInss Brands™, “and we look forward to showcasing the incredible state-of-the-art facility Kevin built in Southwest Florida, and the events we will have there in the very near future.”

“I am extremely excited about the unlimited creative potential between Robert and I that flows from our daily innovation conference calls,” says Kevin Thomas, founder of Alternative Labs. “It’s so rewarding to perform at one’s maximum potential when working with the right like-minded individuals.”

About AmpLIFEi™ and HAPInss Brands™

AmpLIFEi International™ is a health and wellness lifestyle company with exclusive marketing rights for HAPInss Brands’ products serving freelance entrepreneurs. These two Companies combined give customers and freelance entrepreneurs more options to improve their lives in a more complete way. For more information about AmpLIFEi™ please visit www.AmpLIFEi.com

HAPInss Brands™ is a Nutritional Science company providing people with the latest technological advances specific to amplifying the state of wellbeing, also known as happiness. For more information about HAPInss Brands™ please visit www.HAPInss.com .

About Alternative Labs LLC
Alternative Laboratories is a value-added private label contract manufacturer located in Southwest, Florida, specializing in the manufacturing and packaging of liquids, powders, tablets, capsules, cosmetics, and other unique nutritional supplements and delivery systems. Its product formulation abilities and global raw material access provides its broad base of Direct Selling and retail brands and private label clients with unique “first to market” products and cutting-edge innovations. Its state-of-the-art facilities are proudly registered with the FDA, cGMP, Organic, and Kosher certified.

Troy Dooly
Deep South Companies Inc
+1 850-543-2823
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Alternative Labs Tour


Source: EIN Presswire